Biological comparison wild-type zidovudine-resistant isolates human immunodeficiency virus type subjects susceptibility resistance drugs viral endpoint dilution changes proportion zidovudine azidothymidine AZT viruses heterogeneous mixture human immunodeficiency virus type quasispecies patients long-term AZT therapy Several isolates microM AZT susceptible novel cytosine analog sulfur atom carbon pentose ring certain instances cross-resistance strains AZT-resistant displayed susceptibility strains case 